STOCK TITAN

Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Apellis Pharmaceuticals (APLS) has announced its participation in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference. The company's presentation is scheduled for Wednesday, June 11, 2025, at 10:40 a.m. ET. Investors and interested parties can access the live webcast through the 'Events and Presentations' page in the 'Investors and Media' section of Apellis' website. A replay of the presentation will remain available for approximately 90 days after the event.
Apellis Pharmaceuticals (APLS) ha annunciato la sua partecipazione alla 46ª Conferenza Globale Annuale sulla Sanità di Goldman Sachs. La presentazione dell'azienda è prevista per mercoledì 11 giugno 2025 alle 10:40 ET. Investitori e interessati possono seguire la diretta streaming tramite la pagina "Eventi e Presentazioni" nella sezione "Investitori e Media" del sito web di Apellis. La registrazione della presentazione sarà disponibile per circa 90 giorni dopo l'evento.
Apellis Pharmaceuticals (APLS) ha anunciado su participación en la 46ª Conferencia Global Anual de Salud de Goldman Sachs. La presentación de la empresa está programada para el miércoles 11 de junio de 2025 a las 10:40 a.m. ET. Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través de la página "Eventos y Presentaciones" en la sección "Inversores y Medios" del sitio web de Apellis. Una repetición de la presentación estará disponible aproximadamente por 90 días después del evento.
Apellis Pharmaceuticals(APLS)는 다가오는 골드만삭스 제46회 연례 글로벌 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 회사의 발표는 2025년 6월 11일 수요일 오전 10시 40분(동부시간)에 예정되어 있습니다. 투자자 및 관심 있는 분들은 Apellis 웹사이트의 '투자자 및 미디어' 섹션 내 '이벤트 및 발표' 페이지를 통해 생방송 웹캐스트에 접속할 수 있습니다. 발표 녹화는 행사 종료 후 약 90일간 다시보기로 제공됩니다.
Apellis Pharmaceuticals (APLS) a annoncé sa participation à la 46e conférence annuelle mondiale sur la santé de Goldman Sachs. La présentation de la société est prévue pour le mercredi 11 juin 2025 à 10h40 ET. Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct via la page « Événements et Présentations » dans la section « Investisseurs et Médias » du site web d'Apellis. La rediffusion de la présentation restera disponible environ 90 jours après l'événement.
Apellis Pharmaceuticals (APLS) hat seine Teilnahme an der bevorstehenden 46. jährlichen globalen Gesundheitskonferenz von Goldman Sachs angekündigt. Die Präsentation des Unternehmens ist für Mittwoch, den 11. Juni 2025, um 10:40 Uhr ET geplant. Investoren und Interessierte können den Live-Webcast über die Seite "Veranstaltungen und Präsentationen" im Bereich "Investoren und Medien" auf der Website von Apellis verfolgen. Eine Wiederholung der Präsentation wird etwa 90 Tage nach der Veranstaltung verfügbar sein.
Positive
  • None.
Negative
  • None.

WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025 at 10:40 a.m. ET.

The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact: 
Neil Carnahan
neil.carnahan@apellis.com
617.977.5703


FAQ

When is Apellis Pharmaceuticals (APLS) presenting at the Goldman Sachs Healthcare Conference 2025?

Apellis Pharmaceuticals will present at the Goldman Sachs Healthcare Conference on Wednesday, June 11, 2025, at 10:40 a.m. ET.

How can I watch Apellis Pharmaceuticals' (APLS) presentation at the Goldman Sachs conference?

The presentation can be accessed via live webcast on the 'Events and Presentations' page of the 'Investors and Media' section on Apellis' website.

How long will the replay of Apellis' Goldman Sachs conference presentation be available?

The replay of the webcast will be available for approximately 90 days following the event.

What is the Goldman Sachs Annual Global Healthcare Conference that Apellis is attending?

The Goldman Sachs Annual Global Healthcare Conference is a significant industry event where healthcare companies present to investors and analysts. This will be the 46th edition of the conference.
Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Stock Data

2.11B
106.60M
13.86%
103.5%
16.58%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM